Advertising of OTC medicines containing codeine and dihydrocodeine

This document provides guidance on the MHRA’s requirements for the advertising of codeine and dihydrocodeine-containing analgesics.


The guidance covers:

  • Restrictions on the sale of these medicines
  • Requirements when advertising to consumers
  • Restrictions on promotions
  • Advertising to Persons Qualified to Prescribe or Supply

This content is exclusively for PAGB members.

Please login to your PAGB website account to access this content. Or visit our membership pages to find out more about PAGB membership and how you could benefit from our collective and expert voice representing and promoting the sector’s interests.

OTC medicines hub

Here you will find all information relevant to OTC medicines, from codes and guidance, to training workshops.

Visit hub